S. Masera

Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis

C. Pozzilli, L. Prosperini, L. Pinessi, 2015, Multiple sclerosis.

Healthcare resource utilization and costs for extended interval dosing of natalizumab in multiple sclerosis.

V. Morra, M. Triassi, A. Carotenuto, 2022, Neurodegenerative disease management.

Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod

L. Pinessi, P. Cavalla, P. Broganelli, 2014, Multiple sclerosis.

Hepatic recovery after damage produced by sub-chronic intoxication with the cyanotoxin microcystin LR.

C. Aura, L. Giannuzzi, S. Masera, 2008, Toxicon : official journal of the International Society on Toxinology.

Fertility in patients with multiple sclerosis: current knowledge and future perspectives

R. Mutani, P. Cavalla, M. Massobrio, 2006, Neurological Sciences.

Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter

Aristide Merola, Roberto Mutani, Giovanni Luigi Mancardi, 2009, Journal of neuropathology and experimental neurology.

Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation

L. Pinessi, P. Cavalla, T. Mongini, 2014, European journal of neurology.

Multiple sclerosis relapses: a multivariable analysis of residual disability determinants

A. Chiò, P. Cavalla, A. Merola, 2009, Acta neurologica Scandinavica.

Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis

R. Mutani, P. Cavalla, G. Mancardi, 2011, Multiple sclerosis.

Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results

C. Gasperini, R. Totaro, R. Capra, 2020, Neurological Sciences.